DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,046 filers reported holding DANAHER CORPORATION in Q3 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,008 | +3.5% | 12 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2,907 | -95.8% | 12 | -95.6% | 0.00% | -92.9% |
Q1 2023 | $69,336 | +2061.3% | 275 | +2191.7% | 0.01% | +1300.0% |
Q4 2022 | $3,208 | +6.9% | 12 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $3,000 | 0.0% | 12 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $3,000 | -25.0% | 12 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $4,000 | 0.0% | 12 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $4,000 | 0.0% | 12 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $4,000 | +33.3% | 12 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 12 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $3,000 | -97.4% | 12 | -97.7% | 0.00% | -95.5% |
Q4 2020 | $114,000 | +3700.0% | 512 | +4166.7% | 0.02% | +2100.0% |
Q3 2020 | $3,000 | -78.6% | 12 | -88.0% | 0.00% | -75.0% |
Q2 2019 | $14,000 | -46.2% | 100 | -50.0% | 0.00% | -50.0% |
Q1 2019 | $26,000 | +23.8% | 200 | 0.0% | 0.01% | +14.3% |
Q4 2018 | $21,000 | +90.9% | 200 | +100.0% | 0.01% | +75.0% |
Q3 2018 | $11,000 | -45.0% | 100 | -50.0% | 0.00% | -42.9% |
Q2 2018 | $20,000 | +100.0% | 200 | +100.0% | 0.01% | +133.3% |
Q1 2018 | $10,000 | +11.1% | 100 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $9,000 | 0.0% | 100 | -5.7% | 0.00% | 0.0% |
Q3 2017 | $9,000 | 0.0% | 106 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $9,000 | +800.0% | 106 | +1666.7% | 0.00% | – |
Q1 2017 | $1,000 | – | 6 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 6 | 0.0% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 6 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,000 | -94.7% | 6 | -97.6% | 0.00% | -93.3% |
Q3 2014 | $19,000 | -5.0% | 250 | 0.0% | 0.02% | -6.2% |
Q2 2014 | $20,000 | +5.3% | 250 | 0.0% | 0.02% | 0.0% |
Q1 2014 | $19,000 | 0.0% | 250 | 0.0% | 0.02% | 0.0% |
Q4 2013 | $19,000 | +11.8% | 250 | 0.0% | 0.02% | 0.0% |
Q3 2013 | $17,000 | – | 250 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |